Literature DB >> 10679307

Induction of COX-2 expression by nitric oxide in rheumatoid synovial cells.

S Honda1, K Migita, Y Hirai, Y Ueki, S Yamasaki, S Urayama, Y Kawabe, T Fukuda, A Kawakami, M Kamachi, M Kita, H Ida, T Aoyagi, K Eguchi.   

Abstract

Prostaglandins formed by cyclooxygenase (COX) enzymes are important mediators of inflammation. The contribution of inducible COX-2 in the rheumatoid synovium is well documented. In this study, we evaluated the contribution of nitric oxide (NO) to COX-2 expression in rheumatoid synovial cells. Exposure of rheumatoid synovial cells to a NO donor, SNAP, induced COX-2 protein expression in a dose-dependent manner. RT-PCR analysis also demonstrated that COX-2 mRNA was induced in SNAP-treated synovial cells. Dexamethasone at therapeutic concentrations markedly inhibited this NO-mediated COX-2 expression in synovial cells. In contrast to its effect on COX-2 expression, SNAP did not affect the constitutive expression of COX-1 in rheumatoid synovial cells. Our findings suggest that NO is an important modulator of COX-2 expression and that glucocorticoids exert their anti-inflammatory action in rheumatoid synovium, at least in part, by suppression of COX-2 induction. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679307     DOI: 10.1006/bbrc.2000.2228

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.

Authors:  Qianhong Li; Yiru Guo; Yu-Ting Xuan; Charles J Lowenstein; Susan C Stevenson; Sumanth D Prabhu; Wen-Jian Wu; Yanqing Zhu; Roberto Bolli
Journal:  Circ Res       Date:  2003-04-18       Impact factor: 17.367

2.  Induction of cyclo-oxygenase-2 in human endothelial cells by SIN-1 in the absence of prostaglandin production.

Authors:  S Eligini; A Habib; M Lebret; C Créminon; S Lévy-Toledano; J Maclouf
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity.

Authors:  A Law; S Gauthier; R Quirion
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

4.  Salivary antioxidants and metalloproteinases in juvenile idiopathic arthritis.

Authors:  Riva Brik; Irit Rosen; Dana Savulescu; Iris Borovoi; Moshe Gavish; Rafael Nagler
Journal:  Mol Med       Date:  2009-12-28       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.